The Obstetrician & Gynaecologist 2007;9:4:270-275
doi: 10.1576/toag.9.4.270.27358
Copyright © 2007 by the Royal College of Obstetricians and Gynaecologists.
Sentinel node mapping
Nigel Acheson, MD MRCOG, Consultant Gynaecological Oncologist1
1. Centre for Women's Health, Royal Devon and Exeter NHS Foundation Trust, Barrack Road, Exeter EX2 5DW, UK Email: nigel.acheson{at}nhs.net (corresponding author)
Key content:
- Cancers involving the regional lymphatic system around the primary site have a poor prognosis.
- The sentinel node is understood to be the first node to which lymphatic drainage occurs from an organ or area of skin.
- The sentinel node can be identified using a blue dye or radiolabel.
- If the sentinel node does not contain metastatic tumour, the risk of involved regional nodes is small.
- The technique has the potential to reduce the morbidity associated with regional lymphadenectomy.
Learning objectives:
- To understand the sentinel node concept.
- To understand the role of sentinel node biopsy in vulval, cervical and endometrial cancer.
Ethical issues:
- Randomised controlled trials should be performed before the technique can be introduced into routine practice.
Please cite this article as: Acheson N. Sentinel node mapping. The Obstetrician & Gynaecologist 2007;9:270–275.
Keywords cervical cancer / endometrial cancer / sentinel node biopsy / vulval cancer
Copyright © 2007 by the Royal College of Obstetricians and Gynaecologists.